Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03290768Not ApplicableCompleted

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

Role: lead

NCT03612999Not ApplicableCompleted

Data Acquisition to Model Glycemic Response

Role: lead

NCT03252964Not ApplicableCompleted

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics

Role: lead

NCT03294512Not ApplicableCompleted

Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform

Role: collaborator

NCT02528669Not ApplicableCompleted

Patient Ambulation in Post-Op Recovery

Role: collaborator

All 5 trials loaded